Last reviewed · How we verify
Streptomycin injectable
Streptomycin injectable is a Small molecule drug developed by Shanghai Pulmonary Hospital, Shanghai, China. It is currently FDA-approved. Also known as: isoniazid tablets, ethambutol tablets, rifampicin capsules, pyrazinamide tablets.
At a glance
| Generic name | Streptomycin injectable |
|---|---|
| Also known as | isoniazid tablets, ethambutol tablets, rifampicin capsules, pyrazinamide tablets |
| Sponsor | Shanghai Pulmonary Hospital, Shanghai, China |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants (PHASE3)
- The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial (PHASE4)
- Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial (PHASE4)
- Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults (PHASE2)
- WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8 (PHASE2, PHASE3)
- Research on New Regimens for Retreatment Pulmonary Tuberculosis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Streptomycin injectable CI brief — competitive landscape report
- Streptomycin injectable updates RSS · CI watch RSS
- Shanghai Pulmonary Hospital, Shanghai, China portfolio CI
Frequently asked questions about Streptomycin injectable
What is Streptomycin injectable?
Streptomycin injectable is a Small molecule drug developed by Shanghai Pulmonary Hospital, Shanghai, China.
Who makes Streptomycin injectable?
Streptomycin injectable is developed and marketed by Shanghai Pulmonary Hospital, Shanghai, China (see full Shanghai Pulmonary Hospital, Shanghai, China pipeline at /company/shanghai-pulmonary-hospital-shanghai-china).
Is Streptomycin injectable also known as anything else?
Streptomycin injectable is also known as isoniazid tablets, ethambutol tablets, rifampicin capsules, pyrazinamide tablets.
What development phase is Streptomycin injectable in?
Streptomycin injectable is FDA-approved (marketed).
Related
- Manufacturer: Shanghai Pulmonary Hospital, Shanghai, China — full pipeline
- Also known as: isoniazid tablets, ethambutol tablets, rifampicin capsules, pyrazinamide tablets
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing